EFSA Panel on Biological Hazards (BIOHAZ); Norovirus (NoV) in oysters: methods, limits and control options by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
EFSA Panel on Biological Hazards (BIOHAZ); Norovirus (NoV) in oysters: methods,
limits and control options
EFSA publication; Hald, Tine
Link to article, DOI:
10.2903/j.efsa.2012.2500
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA publication (2012). EFSA Panel on Biological Hazards (BIOHAZ); Norovirus (NoV) in oysters: methods,
limits and control options. Parma, Italy: European Food Safety Authority.  (The EFSA Journal; No. 2500, Vol.
10(1)). DOI: 10.2903/j.efsa.2012.2500
  EFSA Journal 2012;10(1):2500
 
Suggested citation: EFSA Panel on Biological Hazards (BIOHAZ); Norovirus (NoV) in oysters: methods, limits and control 
options. EFSA Journal 2012;10(1):2500. [39 pp.] doi:10.2903/j.efsa.2012.2500. Available online:    
www.efsa.europa.eu/efsajournal  
 
© European Food Safety Authority, 2012 
SCIENTIFIC OPINION 
Scientific Opinion on Norovirus (NoV) in oysters: methods, limits and 
control options1 
EFSA Panel on Biological Hazards (BIOHAZ)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
 
 
ABSTRACT 
NoV is highly infectious, and there is no threshold infectivity limit for NoV detected by PCR. The 
probability of becoming infected increases with the dose but depends also on the characteristics of the 
organism, the food matrix and the host factors. The relationship between the number of infectious 
virus particles and the number of virus genome copies detected by quantitative PCR is not a constant, 
and it is important to realise that the infectious risk associated with low level positive oysters as 
determined by real-time PCR may be overestimated. 
Quantitative data on viral load from areas compliant with current EU legislative requirements (E. coli 
standards) during January-March 2010  in 3 selected member states, show that a viral limit of 100, 
200, 500, 1000 or 10.000 NoV PCR copies would result in 33.6-88.9%, 24.4-83.3%, 10.0-72.2%, 7.7-
44.4% or 0-11.1% of non-compliant batches, respectively. Compliance with any of the above NoV 
limits would reduce the number of contaminated oysters placed on the market and therefore the risk 
for consumers to become infected. It is currently not possible to quantify the public health impact of 
different limits 
Microbiological criteria for NoV in oysters are useful for validation and verification of HACCP-based 
processes and procedures, and can also be used by competent authorities as an additional control to 
improve risk management in production areas, during processing and retail. The Panel recommended 
that risk managers should consider establishing an acceptable limit for NoV in oysters to be harvested 
and placed on the market. NoV testing of oysters (standardized CEN method) should be used to verify 
compliance with the acceptable NoV limit established. 
                                                     
1  On request from the Food Safety Authority of Ireland, Question No EFSA-Q-2010-00926, adopted on 8 December 2011. 
2  Panel members: Olivier Andreoletti, Herbert Budka, Sava Buncic, John D Collins, John Griffin, Tine Hald, Arie Hendric 
Havelaar, James Hope, Günter Klein, James McLauchlin, Winy Messens, Christine Müller-Graf, Kostas Koutsoumanis, 
Christophe, Nguyen-The, Birgit Noerrung, Luisa Peixe, Miguel Prieto Maradona, Antonia Ricci, John Sofos, John 
Threlfall, Ivar Vågsholm, Emmanuel Vanopdenbosch.  Correspondence: biohaz@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on NoV in oysters: methods, limits and 
control options: Ana Maria de Roda Husman, William Dore, Soizick Le Guyader, Shaman Muradrasoli, Birgit Noerrung, 
and David Lees for the preparatory work on this scientific opinion and EFSA staff: Ernesto Liebana and Pietro Stella for 
the support provided to this scientific opinion. 
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The most effective public health measure to control human NoV infection from oyster consumption is 
to produce oysters from areas which are not faecally contaminated, particularly given the 
ineffectiveness of current depuration and relaying procedures.  
© European Food Safety Authority, 2012 
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SUMMARY 
The Food Safety Authority of Ireland asked the Panel on Biological Hazards to issue a scientific 
Opinion on: (i) The use of real-time reverse-transcription polymerase chain reaction (rRT-PCR) as a 
means of detection and quantification of Norovirus (NoV) in oysters; (ii) on Limits that do not pose an 
unacceptable risk to consumers for NoV genogroups GI and GII in oysters as determined by real-time 
PCR, and (iii) on Treatment regimes (post-harvest interventions) that can be relied upon to reduce 
NoV counts in oysters.).  
On the use of PCR, the BIOHAZ Panel concluded that PCR-based detection methods exist for NoV in 
bivalve shellfish. Harmonization and standardization are currently ongoing for NoV in shellfish, and 
publication of methods is expected soon. To achieve a good sensitivity separate assays are required for 
NoV GI and GII detection. With the appropriate quality assurance measures, including accreditation 
and proficiency testing, the standardised CEN method is considered suitable for use for detection and 
quantification of NoV in oysters within a legislative context. The Panel also recommended that 
research needs to be conducted to establish the relationship between detection of NoV in oysters by 
PCR and human health consequences. 
On the question of NoV limits, the Panel concluded that: NoV can be frequently detected by rRT-PCR 
in oysters during winter in European areas compliant with current legislative requirements (E. coli 
standards) for which data are available. NoV is highly infectious, and exposure of human volunteers to 
serial dilutions yielded a dose-dependent probability of becoming ill ranging from 0.1 (at a dose of 103 
NoV genome copies) to 0.7 (at a dose of 108 virus genome copies). However, there is no threshold 
infectivity limit for NoV detected by rRT-PCR. From outbreak published data, it can be concluded 
that NoV concentrations detected in oysters linked to human cases varied greatly from less than 
hundred copies to more than ten thousand per gram of material analysed. The probability of becoming 
infected increases with the dose but depends also on the characteristics of the organism, the food 
matrix and the host factors. The relationship between the number of infectious virus particles and the 
number of virus genome copies detected by quantitative PCR is not a constant, and may vary 
depending on environmental conditions including time from the initial release from the host. 
Furthermore, the number of genome copies detected by quantitative PCR may not relate to infectious 
NoV particles, and as a consequence the method can only be used to provide an indirect measure of 
risk, and when considering what is an acceptable level of NoV in oysters, it is important to realise that 
the infectious risk associated with low level positive oysters as determined by rRT-PCR may be 
overestimated. 
Despite observed differences between the ability of NoV GI and GII to cause human infection via 
different transmission routes, there is insufficient knowledge on the dose response for each genogroup 
to allow a distinction. Therefore it is appropriate to consider the total NoV load (GI+GII) when 
establishing microbiological criteria. Quantitative data on viral load from areas compliant with current 
EU legislative requirements (E. coli standards) during January-March 2010  in 3 member states, show 
that a viral limit of 100, 200, 500, 1000 or 10,000 NoV PCR genome copies would result in 33.6-
88.9%, 24.4-83.3%, 10.0-72.2%, 7.7-44.4% or 0-11.1% of non-compliant batches, respectively. 
Compliance with any of the above NoV limits would reduce the number of contaminated oysters 
placed on the market and therefore the risk for consumers to become infected. The lower the limit the 
greater the consumer protection achieved. However, it is not currently possible to quantify the public 
health impact of establishment of different limits.    
Microbiological criteria for NoV in oysters are useful for validation and verification of HACCP-based 
processes and procedures, and can be used to communicate to food business operators and other 
stakeholders what is an acceptable or unacceptable viral load for oysters to be placed on the market. 
Microbiological criteria for NoV in oysters could also be used by competent authorities as an 
additional control to improve risk management in production areas, during processing and retail. 
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The Panel recommended that on the basis of the data presented in this Opinion, risk managers should 
consider establishing an acceptable limit for NoV in oysters to be harvested and placed on the market. 
Competent authorities should consider the use NoV testing of oysters (standardized CEN method) to 
verify compliance with the acceptable NoV limit established. Food business operators should consider 
incorporating NoV testing of oysters to verify their HACCP plans to demonstrate compliance with the 
acceptable level. The quantitative levels of NoV within production areas and batches should be 
investigated further, in order to optimise sampling strategies. Furthermore, sampling schemes to 
comply with NoV criteria should be risk based, e.g. considering seasonality, faecal pollution levels, 
community outbreaks, and variability from year to year. Finally, an EU-wide baseline survey on NoV 
contamination in oysters should be considered, in order to estimate consumer exposure and to allow 
quantification of the impact on human exposure related to establishment of microbiological criteria.  
On the question of post-harvest interventions to reduce NoV counts in oysters, the Panel concluded 
that: Current treatment regimes for products placed live on the market (depuration and relaying) as 
commonly practised do not effectively reduce NoV in oysters. Depuration and relaying may be 
improved by optimising process parameters to enhance NoV reduction (e.g. depuration times, water 
temperature). However, limited data is currently available. Alternative treatments such as commercial 
heat treatment and high pressure may be effective for NoV inactivation, but give rise to organoleptic 
changes which may be unacceptable to consumers. The most effective public health measure to 
control human NoV infection from oyster consumption is to produce oysters from areas which are not 
faecally contaminated, particularly given the ineffectiveness of current control regimes. 
The Panel recommended that control measures for NoV in oysters should focus on avoiding 
contamination by either preventing human faecal contamination in mollusc production areas, or 
restricting commercial harvesting from faecally-contaminated areas. In addition, further studies are 
needed to establish and optimise the effectiveness of depuration and relaying for NoV reduction using 
the standardised CEN method. 
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BACKGROUND AS PROVIDED BY THE FOOD SAFETY AUTHORITY OF IRELAND 
Norovirus (NoV) is a major cause of epidemic and sporadic cases of acute gastroenteritis in adults and 
children in Ireland and around the world. In 2009 there were 16474 reported noroviral infections in 
Ireland. NoV causes outbreaks in communities and is particularly prevalent during the winter months. 
NoV is transmitted through consumption of food and water contaminated with faecal matter, through 
person-to-person contact and through contact with infected surfaces.  
Bivalve molluscs are a well documented source of noroviral infection since they have the ability to 
accumulate and concentrate NoV particles by filtration of water contaminated with faeces. NoV is a 
persistent problem in coastal waters during the winter months leading to the contamination of bivalve 
mollusc production areas. Oysters contaminated with NoV pose a particular risk to human health since 
they are routinely consumed raw. 
In the EU, protection of shellfish waters has been achieved by a combination of environmental surveys 
of the area surrounding production beds and monitoring of faecal contamination of waters by testing 
bivalve molluscs for levels of E. coli above a specified limit5 . However, the use of indicator 
microorganisms of faecal pollution is not a reliable means of determining the extent of NoV 
contamination of shellfish.  NoV detection and quantification is difficult as they are non-culturable 
and their biologically heterogeneity limits the applicability of immunological and serological methods 
for identification purposes. However, in recent years real time-PCR has enabled confirmation and 
quantification of NoV.  
In January 2010 the FSAI was notified of noroviral food poisoning incidents linked epidemiologically 
to an oyster production area in Ireland6. The food incident eventually resulted in 31 reported food 
poisoning events in England and Ireland with a total of 76 people reported ill, several of whom had 
NoV detected in stool specimens. The oyster production area in question is a class-A growing area for 
shellfish, which means that shellfish may be consumed directly without further treatment.  Both prior 
to, and during this incident the testing results for E. coli in the oysters were below the legal limit for a 
Category-A area. However, real time-PCR was able to demonstrate the presence of both genogroup 
one (GI) and genogroup 2 (GII) NoV. Copy numbers ranged between 200-7000 per gram for GII with 
less contamination by GI, which tended to be sporadically positive and rarely above the level of 
quantification.  
The oyster production area was closed as soon as the epidemiological link was suspected. However, 
then as now, the producers were compliant with all EC legislative requirements including 
microbiological standards. This creates a problem for the competent authority as there is no clear 
criterion for re-opening the production area. Surveillance of oysters from the area during March and 
April by real time-PCR continues to show NoV present in numbers between 300 and 2500 per gram 
albeit reduced from levels found during February.  
Historic monitoring results show that NoV is often present in oysters in low numbers during the winter 
months and normal depuration regimes are not effective at removing the virus. Yet no reported human 
illness has been attributed to consumption of these contaminated oysters. Reports in the scientific 
literature have suggested human resistance to NoV7. In addition it is suggested that PCR methods will 
overestimate the number of infectious NoV particles.  
                                                     
4  Provisional figures reported by the Health Protection Surveillance Centre (HPSC) 
5   <230MPN/100g Regulation (EC) 2073/2005 as amended 
6  The information provided was accurate to the best knowledge of the FSAI at the time of submitting this mandate to EFSA. 
A recent publication from the UK has shown more accurate figures on the number of outbreaks, the number of cases and 
has also shown that oysters from UK suppliers were also involved along with those from the Irish suppliers 
(www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19524)  
7 Hutson et al (2002) Norwalk virus infection and disease is associated with ABO histo-blood group type. Journal of 
Infectious Diseases. 185, 1335-1337 : Lindesmith et al (2003) Human susceptibility and resistance to Norwalk virus 
infection. Nature Medicine. 9,5,548-553 
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It is reasonable to conclude that there may be quantifiable level of NoV in oysters as judged by real 
time PCR that may not pose an unacceptable risk to consumers. If this was the case then oyster beds 
could be re-opened on the basis of real time-PCR detection and quantification of NoV. It is essential 
that there is a scientific basis for re-opening closed shellfish production areas liked to NoV outbreaks. 
This is an issue faced by competent authorities both in Europe and around the world and is not solely 
confined to Ireland. 
TERMS OF REFERENCE AS PROVIDED BY THE FOOD SAFETY AUTHORITY OF IRELAND 
The Food Safety Authority of Ireland requests that EFSA provides a scientific Opinion on: 
1) The use of real-time PCR as a means of detection and quantification of NoV in oysters. 
2) Limits that do not pose an unacceptable risk to consumers for NoV genogroups GI and GII in 
oysters as determined by real-time PCR (e.g. copy number per gram).  
3) Treatment regimes (post-harvest interventions) that can be relied upon to reduce NoV counts 
in oysters. 
Norovirus in oysters
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ASSESSMENT 
1. Introduction 
Norovirus (NoV) is a genus in the family Caliciviridae, a group of non-enveloped, icosahedral viruses, 
having a single-stranded positive sense RNA genome. Bivalve molluscs are a well documented source 
of noroviral infection since they have the ability to accumulate and concentrate NoV particles by 
filtration of water contaminated with faeces. NoV is a persistent problem in coastal waters during the 
winter months leading to the contamination of bivalve mollusc production areas. Oysters contaminated 
with NoV pose a particular risk to human health since they are routinely consumed raw. 
In June 2011 EFSA published a scientific Opinion updating the present knowledge on the occurrence 
and control of food-borne viruses8.  In this opinion it was recommended to focus on preventive 
measures to avoid viral contamination rather than trying to remove/inactivate these viruses from food. 
In addition it was recommended to introduce microbiological criteria for viruses in bivalve molluscs 
unless they are labelled: “to be cooked before consumption”, and also to introduce microbiological 
criteria for classification of bivalve molluscs production areas. Such criteria could be used by food 
business operators to validate their control options. Furthermore it was emphasised that a virus 
monitoring programme for compliance with these criteria should be risk based according to the 
findings of a sanitary survey and that using an E. coli standard for monitoring and classification of 
bivalve mollusc production areas provides general information about the background level of faecal 
contamination, and should be retained. 
In the present mandate, EFSA is asked for a scientific opinion on the use of real-time reverse- 
transcription polymerase chain reaction (rRT-PCR) as a means of detection and quantification of NoV 
in oysters; and on limits that do not pose an unacceptable risk to consumers for NoV genogroups GI 
and GII in oysters as determined by real-time PCR (e.g. copy number /gram). While establishment of 
acceptable vs. unacceptable risk is a risk management task, the present opinion focuses on dose-
response relationships, rRT-PCR detection methods, interpretation of NoV RT-PCR results, and on 
qualitative and quantitative occurrence of NoV in oysters. Also, the consequences, on compliance and 
thereby consumer exposure, of introducing different acceptable limits are elucidated. Ideally, the 
acceptable limit of a criteria should be linked through risk assessment to a realistic and appropriate or 
current level of protection, but data needs (availability of representative data on Nov in oysters across 
EU) and difficulties in knowing and recording the real number of human NoV-infections caused by 
oysters, makes this exercise impossible at present. In addition to rRT-PCR methods and results, the 
opinion also covers postharvest treatment regimes (post-harvest interventions) that can be relied upon 
to reduce NoV counts in oysters. 
2. Dose-response relationship 
The first paper reporting a volunteer study with Norwalk virus was published in 1972 and reported 
serial dilutions of a stool filtrate inducing disease through 3 serial passages in volunteers (Dolin et al., 
1972). The frequency of disease remained high throughout these passages, with unchanged clinical 
spectrum but a slightly shortened incubation period (Dolin et al., 1972). Dose information was not 
obtained in these studies due to lack of virus detection methods; however, the agent in the Norwalk 
virus outbreak derived filtrates was still infectious for human volunteers after ether, acid, or heat 
treatment for 30 minutes at 60°C. Following this study, Teunis et al. showed that exposure of human 
volunteers to serial dilutions of the original inoculum of NoV (characterized as GI.1 Norwalk virus) 
yielded a dose-dependent probability of becoming ill ranging from 0.1 (at a dose of 103 NoV genomes) 
to 0.7 (at a dose of 108 virus genomes) (Teunis et al., 2008). 
                                                     
8  EFSA Panel on Biological Hazards (BIOHAZ); Scientific Opinion on An update on the present knowledge on the 
occurrence and control of foodborne viruses. EFSA Journal 2011;9(7):2190. [96 pp.] doi:10.2903/j.efsa.2011.2190. 
Available online: www.efsa.europa.eu/efsajournal 
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After the initial outbreak of Norwalk virus in the early 1970’s, this virus was hardly detected. Dose-
response relations for prevalent NoV, such as GII, or any other GI NoV than Norwalk virus, have not 
been published to date.  
The probability of becoming infected increases with the dose, as was observed in volunteer studies and 
during outbreaks (de Wit et al., 2007; ter Waarbeek et al., 2010; Teunis et al., 2008; Visser et al., 
2010). 
In addition, a correlation has been found between the number of NoV genome copies in oysters, and 
the amount of self reported illness in a specific study in the UK (Lowther et al., 2010) with the highest 
NoV RNA levels resulting in the highest rate of reported illness, suggesting a linkage between virus 
RNA levels and health risks. 
Very few volunteer studies have been conducted with contaminated oysters. The first report described 
the use of volunteers to test depurated (during 7 days) oysters before marketing, with a demonstration 
of quite a large illness frequency (up to 37%) depending on the time of the year, and oyster sampling 
location (Grohmann et al., 1981). Unfortunately at this time no quantitative detection method for NoV 
was available. A second volunteer study was recently conducted to evaluate high pressure to inactivate 
NoV GI.1 Norwalk resulting in no NoV infection among subjects receiving high pressure-treated 
oysters as determined by RT-PCR detection of NoV RNA in subject samples (Leon et al., 2011). 
In general, there is limited data on the dose response for NoVs in humans. The majority of infections 
recorded in the human population arise from NoV GII.4 genotypes perhaps inferring a lower 
infectious dose associated with this genotype than other genotypes. However greater virus survival and 
differences in host immunity may also play a role. By contrast, there is evidence that a 
disproportionate number of foodborne illnesses (including those caused by oysters) are associated with 
NoV GI genotype infections (Verhoef et al., 2010). This is possibly due to greater environmental 
survival of NoV GI genotypes, or to differential uptake and retention in oysters (Maalouf et al., 2011). 
Despite these apparent differences between the ability of NoV GI and GII to cause human infection 
via different transmission routes, there is insufficient knowledge on the dose response, illness rate or 
severity of symptoms for each genogroup to allow a distinction to be made between them when setting 
a standard in oysters. 
3. Detection of NoV in oysters 
As these viruses cannot be cultured, laboratory detection methods depend primarily on electron 
microscopy (EM) (Duizer et al., 2004), enzyme-linked immunosorbent assay (ELISA) and reverse- 
transcription polymerase chain reaction (RT–PCR), the choice of detection technique is depending on 
the sample type. Both EM and ELISA are reliable diagnostic tools for detection of NoVs in clinical 
samples, but they cannot be used for direct detection of NoVs in environmentally contaminated 
samples, such as bivalve shellfish or other foods, due to low levels of virus and matrix complexity. 
Despite extensive attempts by several investigators testing different human and animal cell lines, no 
efficient cell culture amplification process has been found yet (Duizer et al., 2004; Guix et al., 2007; 
Lay et al., 2010). A cell culture system for human NoV was recently published (Straub et al., 2007). 
The authors demonstrated a limited growth of both GI and GII in vitro, using a three-dimensional 
model of human intestine epithelial cells under conditions of physiological fluid shear in rotating wall 
vessel bioreactors (Straub et al., 2007).  At present, no other laboratories have been able to reproduce 
this result. Another cell culture model has been investigated, but results need to be confirmed (Leung 
et al., 2010).  Although NoVs are present in several animal species such as swine, cattle and mice, the 
murine NoV is the only one that grows in cell culture systems. The murine NoV has been suggested as 
an experimental model system for the study of human NoV, specifically to improve the understanding 
of NoV replication, phatogenesis, virus-host interactions and host immune responses (Virgin et al., 
2006). The murine NoV may be not as resistant as other NoVs (Sattar et al., 2011). 
Norovirus in oysters
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In the absence of other assays with detection levels low enough to detect viruses directly, RT–PCR is 
the only published method that offers the possibility of direct detection of NoVs in environmental 
samples such as bivalve shellfish or other foods (Lees, 2000; Mattison et al., 2010). Its high sensitivity 
and accuracy enables the detection of as little as 10 virus copies. rRT-PCR, performed with adequate 
controls and standard curves, is therefore increasingly used to quantify virus. Such high analytical 
sensitivity is a prerequisite for the detection of virus in food, because the number of viral particles 
needed to cause infection may be very low. There are various methods to assess the presence of 
inhibitors and determination of inhibition of target amplification due to matrix interference (Atmar et 
al., 1995; Le Guyader et al., 2000; Schwab et al., 1998). Adding a PCR external amplification control 
(EAC) to the reactions mixture is an absolute requirement to avoid any competitive effects and 
circumvent the loss of the quantitative properties of the assay. 
In the 1990s, targets for RT-PCR assays were found in genome conserved areas, such as the 
polymerase gene, the ORF1-ORF2 junction, or areas in the capsid coding region. Unfortunately, no 
single primer pair will detect all NoVs, but many assays that detect a broad range of strains are 
currently available (Mattison et al., 2009; Vinje et al., 2004). In order to ensure adequate sensitivity 
and specificity, it is important to achieve a good quality of nucleic acid extract, and to include all 
controls needed to detect false negative or positive results. 
3.1. General background on methods for viruses 
Viruses can be present in shellfish in very low numbers and still pose a risk to consumers, making it 
necessary to develop highly sensitive viral extraction methods to ensure virus recovery from shellfish 
tissues. The observation that viruses are concentrated in digestive diverticulum tissues led to the 
development of a method that represented a major step in the improvement of extraction 
methodologies (Atmar et al., 1995; Metcalf et al., 1980). This observation was subsequently confirmed 
by detection of hepatitis A virus (HAV) (Romalde et al., 1994) as well as through the tissue-specific 
quantification of infectious enteric adenoviruses and rotaviruses in mussels previously contaminated 
by bioaccumulation of such viruses, and similarly of Norwalk virus in oysters and clams (Abad et al., 
1997; Schwab et al., 1998). More recently the demonstration that NoV bind specifically to digestive 
tissues (DT) confirms this observation (Maalouf et al., 2010b). Using rRT-PCR, the concentration 
observed in DT, that represent usually about one tenth of the total animal weight for oysters and 
mussels, was at least two log higher than concentration detected in other tissues such as gills or mantle 
(Maalouf et al., 2011). Analysis of DT provides several advantages, including increased sensitivity, 
decreased processing time and decreased interference with RT-PCR by inhibitory substances (Atmar 
et al., 1995). With the exception of small species, such as clams or cockles, in which dissection may 
be technically difficult, most of recent methods are based on dissected tissues and thus will be 
discussed here.  
Extraction of enteric viruses from shellfish is based on several steps: virus elution from shellfish 
tissues, recovery of viral particles, and then virus concentration. The weight analyzed generally ranges 
from 1.5 to 2 g of digestive tissues. Some methods propose larger weights for the first step but 
thereafter analyze only a fraction of the extracts (Boxman et al., 2006; Depaola et al., 2010; Kittigul et 
al., 2008). Viruses are eluted from shellfish digestive tissues using various buffers (i.e. chloroform-
butanol or glycine) before being concentrated either by polyethylene glycol precipitation or 
ultracentrifugation (Atmar et al., 1995; Milne et al., 2007; Myrmel et al., 2004; Nishida et al., 2003). 
Direct lysis of virus particles has also been used, including methods utilizing proteinase K or Trizol to 
destroy shellfish tissues or Zirconia beads and a denaturing buffer for virus and/or nucleic acid elution 
(Greening and Hewitt, 2008; Jothikumar et al., 2005; Kittigul et al., 2008; Lodder-Verschoor et al., 
2005; Lowther et al., 2008; Umesha et al., 2008).  
In addition to the in-house protocols that have been used for nucleic acids extraction and purification, 
a number of commercial kits can also be successfully applied to accomplish this task. Advantages of 
the commercial kits used for nucleic acid purification include their reliability, reproducibility and ease 
Norovirus in oysters
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of use. Most of these kits are based on guanidium lysis followed by capture of nucleic acids on 
columns, beads or silica (Costafreda et al., 2006; de Roda Husman et al., 2007; Depaola et al., 2010; 
Fukuda et al., 2008; Kingsley et al., 2007; Le Guyader et al., 2009; Lodder-Verschoor et al., 2005; 
Milne et al., 2007; Nenonen et al., 2008; Nishida et al., 2003; Umesha et al., 2008).  
One of the goals of extraction methods is to remove inhibitors of the RT and PCR reactions 
sufficiently to allow detection of viral nucleic acids. Polysaccharides present in shellfish tissue are at 
least one substance that can inhibit the PCR reaction (Atmar et al., 1993). Elimination of inhibitors is 
difficult to evaluate and depending on the time of the year and shellfish life, different compounds may 
be present (Burkhardt and Calci, 2000; Di Girolamo et al., 1970). External amplification control 
standards are used to detect the presence of significant sample inhibition, and the amount and 
frequency of sample inhibition has varied depending upon the shellfish tissue being analyzed (Atmar 
et al., 1995; Le Guyader et al., 2000; Schwab et al., 1998). Recent advances in food virology re-
enforce the need of harmonization of methods as well as addressing quality assurance and quality 
control (Pinto and Bosch, 2008).  
The addition of an external virus to a shellfish sample has been proposed as a control to evaluate the 
extraction efficiency of molecular virus detection methods (Costafreda et al., 2006; Depaola et al., 
2010; Le Guyader et al., 2009; Lowther et al., 2008; Nishida et al., 2007). An ideal candidate would 
have the following properties: (i) it would be an encapsidated RNA virus with properties similar to the 
enteric viruses contaminating shellfish, (ii) it would normally not be present in field samples (thus 
RNA phages may be problematic), and (iii) it would be non-pathogenic. Based on these considerations 
a number of viruses such as Mengovirus or Echo type 9 (Picornaviridae family members) (Costafreda 
et al., 2006; Le Guyader et al., 2009; Nishida et al., 2007) or non-human calicivirus such as a feline 
calicivirus or San Miguel sea lion virus (Depaola et al., 2010; Lowther et al., 2008) have been 
proposed as a control for extraction efficiency.  
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Table 1:  Overview of methods used for virus detection in shellfish.  
Shellfish Mass analysed Virus Elution Virus 
Concentration 
Mass used for 
nucleic acid 
extraction 
Nucleic acid extraction % of sample used 
for RT-PCR 
Reference 
Oysters 25 g Glycine PEG 0.5g QIAamp (Qiagen) 3 (Shieh et al., 1999) 
 50 g Water PEG, precipitate 0.5g Boiling nc (Chung et al., 1996) 
 18 g Glycine Ultracentrifugation 1g GuSCN 10 (Muniain-Mujika et al., 2003) 
 50 g Sonication PEG nc GuSCN nc (Green et al., 1998) 
 25 g Glycine PEG 0.4g Tri-reagent (Sigma) 10 (Kingsley and Richards, 
2001) 
 1.5 g DT Chloroform-but, CatFloc 
(Calgon) 
PEG 1.5 g Prot. K, CTAB 20 (Atmar et al., 1995) 
 1.5 g DT Gycine-threonine PEG 0.12g GuSCN+ QIAamp 16 (Beuret et al., 2003) 
 1.5 g DT Chloroform-but, Cat-floc  PEG 1.5 g Prot. K, CTAB 20 (Schwab et al., 2001) 
 1.5 g DT Phosphate saline buffer 
pH7.4 Chloroform-but, 
Cat-floc 
Ultracentrifugation 1g QIAamp 25 (Nishida et al., 2003) 
 1.5 g DT Zirconia beads nc 0.09g RNEasy (Qiagen) 6 (Lodder-Verschoor et al., 
2005) 
 DT of 1 oyster Stainless-steels beads nc nc Silica and guanidium 17 (Ueki et al., 2005) 
 2 g DT Proteinase K nc 0.01g GuSCN 4* (Jothikumar et al., 2005) 
 10g DT TRIzol (Gibco) nc 0.08g GuSCN 8 (Boxman et al., 2006) 
 1.5 g DT Zirconia beads nc nc RNeasy 5 (Schultz et al., 2007) 
 nc Glycine, pH 10 Ultracentifugation nc Silica-method 10 (Hernroth and Allard, 2007) 
 DT of 3 oys. Phosphate saline buffer PEG 1 g QIAamp 5 (Fukuda et al., 2008) 
 5 g DT Buffer pH 8 + Prot. K nc 0.05 g Silica and guanidium 10 (Greening and Hewitt, 2008) 
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Shellfish Mass analysed Virus Elution Virus 
Concentration 
Mass used for 
nucleic acid 
extraction 
Nucleic acid extraction % of sample used 
for RT-PCR 
Reference 
 25 g flesh Adsorption-alkaline 
elution 
PEG (twice) 5 g flesh RNeasy 3 (Kittigul et al., 2008) 
 DT of 6 oysters Buffer pH 8 + Prot. K - nc Silica and guanidium 11 (Lowther et al., 2008) 
 1.5 g DT Glycine pH 9 PEG 1.5 g Nuclisens (BioMerieux) 20 (Le Guyader et al., 2009) 
 5 g DT Finely chopped + 
Proteinase K 
- 0.15g RNeasy 4 (Gentry et al., 2009) 
 25 g flesh Adsorption elution PEG (twice) 25 g (flesh) RNeasy 6 (Depaola et al., 2010) 
 2 g DT Tryptose phosphate broth 
and chloroform butanol 
PEG nc Silica and guanidium nc (Rigotto et al., 2010) 
Mussels 20 g Glycine, cat-Floc Antigen capture 0.04g QIAamp 21 (Lee et al., 1999) 
 50 g Glycine PEG nc Guanidium, CsCl 100 (Croci et al., 2000) 
 100 g Glycine Ultracentrifugation 1 g GuSCN 5 (Pina et al., 1998) 
 10 g Glycine PEG 0.8 g RNEasy 50 (Chironna et al., 2002) 
 25 g Threonine PEG nc GuSCN 2.5 (Mullendore et al., 2001) 
 25 g DT Glycine Ultracentrifugation 1.5 g TRIzol  (Gibco)+ Boom 6 (Myrmel et al., 2004) 
 2 g DT Glycine Ultracentrifugation 0.1 g GuSCN 10 (Hernroth et al., 2002) 
 75g total Glycine buffer pH 9.2 PEG 8.3 g Guanidium 100 (Croci et al., 2007) 
 1.5 g DT Glycine buffer pH 9.5 PEG 1.5 Nuclisens 5 (Vilarino et al., 2009) 
 25 g DT Glycine buffer pH 9.2 PEG twice 0.75 g Nucleospin RNA  
(Macherey-Nagel) 
4 (Serracca et al., 2010) 
Clams 25 g Glycine, chlorof. Ultracentrifugation 1.25 g Nucleospin RNA 10 (Sunen et al., 2004) 
 1.5g DT Chlorof-but, CatFloc PEG 0.07 g RNeasy 6 (Costafreda et al., 2006) 
 1g DT Phosphate-buffered saline Ultracentrifugation nc QIAamp 1.5 (Hansman et al., 2007) 
PEG: polyethylene glycol 
CTAB: cetyltrimethylammonium bromide 
nc: not communicated in the paper 
- : no concentration step. 
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The key objective for developing procedures for shellfish analysis, is to end up with result in a low 
volume of viral concentrate, and subsequently with a highly purified nucleic acid preparation with no 
inhibitory effect to the PCR. The sensitivity of the RT-PCR is essentially the result of two related 
factors: (i) the efficiency of recovery of the extraction procedure applied to the shellfish sample, and 
(ii) the degree of final purity of the recovered virus. As shown in table 1, some methods begin with a 
large mass of sample and then extract only a portion, while other protocols are based on small weight 
being all extracted up to the last step. In the RT-PCR reaction the volume of sample analyzed is 
always very small, we can assume that all rRT-PCR assays have a limit of sensitivity above 10 viral 
units/ g of digestive tissues. 
Even with the application of highly sensitive molecular methods such as PCR, the detection of NoV in 
shellfish constitutes a challenge due to: (i) the low number of virus particles needed to cause disease, 
(ii) the high variability of the virus genome, and (iii) the possible presence of inhibitory substances in 
such a complex food matrix. It must therefore be recognised that as with any method, the rRT-PCR 
procedure employed may underestimate the number of NoV particles present in sample. In particular 
the specificity of the primers employed is of critical importance. NoVs, as all RNA viruses, are prone 
to point mutation and recombination, which often gives rise to new variants of the viruses. It is 
important that PCR methods accommodate viral variation. It is therefore possible that a range of NoV 
genotypes may go undetected depending on the primers employed. This issue is dealt with, to some 
extent, in the proposed standardised method requiring the use of validated cross-reactive primers that 
are directed towards the ORF1-ORF2 junction region for either GI or GII NoV genotypes (Jothikumar 
et al., 2005; Loisy et al., 2005, Le Guyader et al. 2009). However, because of the rapid rate of 
evolution of NoVs rough recombination and mutation, variants of recognised genotypes and novel 
genotypes are regularly reported. These novel genotypes and variants may or may not be detected by 
currently validated primers potentially leading to false negative results in the future.  
Comparing methods is a difficult challenge as no reference materials are available. However it is 
important to point out that many methods have never been applied to naturally contaminated shellfish.  
The EU Reference laboratory for microbiological and viral contamination of bivalve molluscs (Cefas, 
Weymouth, UK) has, since 2003, conducted annual proficiency testing for detection of NoV in 
shellfish. The reports are available on the EU-RL website (www.crlcefas.org). Participants include 
most European National reference laboratories and specialist Government laboratories in a number of 
third countries. For example in the latest distribution in 2011 there were a total of 27 participants 
including 15 EU National Reference Laboratories (NRLs) and 8 third country laboratories including 
laboratories in Australia, Canada, Chile, Korea, New Zealand, Peru and Singapore. A variety of 
methods were used by laboratories participating in this proficiency test distribution. For virus 
extraction, 72% of labs providing information used proteinase K digestion of chopped digestive 
glands. 17% used the Atmar method (chloroform/butanol extraction in the presence of a flocculating 
agent on homogenised glands, followed by PEG/NaCl precipitation) (Atmar et al., 1995). Other labs 
used in-house methods. For RNA extraction 46% used the Biomerieux nuclisens magnetic extraction 
reagents, 35% used QIAGEN RNA extraction kits, other labs used other kits or in-house methods. For 
PCR, 85% used rRT-PCR, whilst 15% used conventional RT-PCR. Of those using real-time, 78% 
used one-step RT-PCR whereas 22% used two-step RT-PCR. A wide variety of PCR primer and probe 
combinations were used: for NoV GI, 10 combinations were used; for NoV GII, 6 combinations were 
used. However all sets used targeted the highly conserved ORF1/2 junction. Proficiency test samples 
distributed for NoV have included both stabilised virus from clinical samples (lenticules) and bivalve 
molluscs samples (either whole animal or dissected digestive diverticulum). Laboratory performance 
has, in general, been good for clinical samples but more problematical for matrix (shellfish) samples. 
For example in the 2011 distribution, sensitivity for lenticules was high (24/27 labs scored 100%) 
whereas sensitivity for shellfish samples was more variable (15/27 labs scored 100%). To illustrate the 
issue, 6 of the 27 laboratories participating failed to detect any NoV in an oyster sample responsible 
for a large international outbreak of NoV gastroenteritis, and a further 5 laboratories detected only 1 of 
the 2 genogroups of NoV present in the sample. It is clear from the results of proficiency testing that 
shellfish are a demanding matrix when compared with high titre clinical samples, and that the variety 
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of methods in use cannot be assumed to give equivalent results. Comparison of laboratory 
performance against test methodology used during both the 2011 distribution and previous rounds 
suggest the use of more standardised methods (as described below) generally results in better 
performance. For example in the 2011 distribution, indicators of good performance (defined as >80% 
sensitivity with shellfish samples) versus poor performance (<40% sensitivity with shellfish samples) 
were: the use of the standardised nuclisens approach for RNA extraction (86% of labs achieved good 
performance vs. 36% of labs using other methods), and the use of rRT-PCR (68% of labs achieved 
good performance vs. 25% of labs using conventional PCR). The proficiency testing data also clearly 
shows that some laboratories using in-house methods may fail to detect NoV in samples that have 
biologically relevant levels of virus i.e. they have caused an outbreak. This evidence underpins the 
importance of standardisation of methods and demonstration of their fitness for purpose through 
validation. 
3.2. Standardisation of methods specifically in oysters 
A major factor limiting the uptake of NoV testing into regulatory food controls for oysters is the 
current absence (world-wide) of any standardised and validated methods for detection of viruses in 
foods. In 2004 the European Committee of Standardisation (CEN) initiated the development of a 
standard method for detection of NoV in foodstuffs, including bivalve molluscs (e.g. oysters), based 
on PCR (Lees and TAG4 CW, 2010). The standard developed by a working group of expert European 
laboratories is now well advanced and due for publication in 2012 (www.cen.eu, WI number 
00275167). Bivalve molluscs present a challenging matrix and the standard method needed to be 
capable of extracting low levels of contaminating virus and presenting them in a non-inhibitory extract 
to a sensitive PCR assay. Key aspects of the developing method were tested by inter-laboratory 
evaluations to ensure robust performance. Dissected digestive diverticulum (digestive gland) is used as 
the starting material for bivalve molluscs with further enzymatic digestion using proteinase K 
(Jothikumar et al., 2005). Nucleic acid is then extracted from digested extracts using guanidine 
thiocyanate (GITC) to denature viral coat proteins in combination with magnetic silica particles to 
bind released nucleic acid, purified through successive washing stages, before final elution in a small 
volume. Reverse transcription and PCR utilises a one-step approach using specific primers in order to 
simply the procedure as much as possible. However, commercial one-step kits must utilise enzymes 
specifically engineered for use with low abundance targets. TaqMan PCR real-time chemistries are 
stipulated for the amplification since: the closed tube format is less susceptible to contamination; is 
logistically efficient; incorporates a probe based confirmation step; can be quantitative; and is more 
amenable to standardisation than conventional PCR. To maximise sensitivity real-time PCR assays are 
run separately for NoV GI and GII. Cross-reactive real-time PCR primers and probes are directed in 
the ORF1-ORF2 junction region for NoV (Jothikumar et al., 2005; Loisy et al., 2005,  Le Guyader et 
al. 2009). Exact primer/probe configuration within these regions is flexible to accommodate potential 
future strain variability. However the standard requires the use of peer reviewed primers/probes shown 
to be sufficiently sensitive and cross-reactive. The standard includes an informative annex with 
recommended primers/probes suitable for detection of all current strains of human NoV. The method 
is highly sensitive in order to detect the low levels of virus found in environmentally contaminated 
samples and hence also vulnerable to both cross-contamination (false positives) and potential matrix 
interferences (false negatives). Thus a comprehensive suite of controls was also developed to cover: 
positive and negative process controls; negative RNA extraction control; positive RT-PCR and RT-
PCR inhibition controls; negative and positive PCR controls. The positive process control measures 
the recovery of virus during the whole extraction and test procedure using a heterologous non-
enveloped positive-sense ssRNA virus spiked into the test sample and assayed in parallel with the 
target viruses. During the development of the standard inter-laboratory studies by the working group 
successfully utilised the MC0 strain of Mengo virus (Costafreda et al., 2006) as a process control. The 
negative process control is a known negative sample that is taken through the entire extraction 
procedure and analysed. The RT-PCR inhibition control checks for potential matrix suppression by 
comparison of amplification of an external RNA template added to test material and a control well. 
Taken together the controls generate data on all aspects of the assay and are utilised to determine the 
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acceptability of test performance against established quality control criteria. Quantitation is based on a 
plasmid DNA calibration curve for each assay (NoV GI, NoV GII) with plasmid DNA concentration 
measured using spectrometry at 260nm. Results are reported in the standardised form of detectable 
virus genome copies per gram of digestive gland. Formal validation studies are planned to characterise 
the method according to the international requirements. 
The developing CEN standard requires laboratories to report results in relation to: (i) the theoretical 
limit of detection (tLOD) - a level that constitutes the smallest quantity of target that can in theory be 
detected. This corresponds to one genome copy per volume of RNA tested in the target assay but will 
vary according to the test matrix and the quantity of starting material; (ii) The practical limit of 
detection (pLOD) - the lowest concentration of target in a test sample that can be reproducibly 
detected (95% confidence interval), as demonstrated by a collaborative trial or other validation; (iii) 
The limit of quantification (LOQ) - the lowest concentration of target in a test sample that can be 
quantitatively determined with acceptable level of precision and accuracy, as demonstrated by a 
collaborative trial or other validation.  
The theoretical limit of detection (tLOD) in genome copies/g digestive tissues corresponds to the 
detection of a single target molecule in the total volume of RNA analysed for each sample and target. 
This figure is dependent on the volume of homogenate retained following treatment of the 2g portion 
of digestive tissues with proteinase K solution, however for a sample producing 2ml homogenate the 
tLOD is 20 copies/g, and for a sample producing 3ml it is 30 copies/g. pLODs and LOQs for detection 
of NoV in shellfish using the CEN method have been established by some laboratories but have not 
yet been published. The intention of the CEN working group is to establish reference LOD and LOQ 
values through collaborative validation trials, these trials have not yet been performed. If virus 
standards are adopted into EU Official Controls then it is a legal requirement under Regulation 
882/2004 for the performance characteristics of test methods to be established (validated) and this will 
include determination of LOD and LOQ. This is also a requirement of test method accreditation under 
ISO 17025 which is also required of methods used for determining compliance with EU Official 
Controls. In considering possible legislative standards it is obviously imperative for utilised methods 
to have an LOQ demonstrably below the proposed legislative level. With the CEN method it is not 
possible to quantify numbers of viral particles below 100 genome copies per gram of digestive 
diverticulum. Clearly therefore legislative standards below this level are unlikely to be analytically 
feasible using present methodology. 
3.3. Interpretation of NoV RT-PCR results 
The development of a robust and reliable quantitative real-time PCR method for the detection of NoV 
in oysters is a major technical advance. It has the potential to provide a valuable tool for risk 
assessment purposes. However it must be recognised that the methodology and the current state of 
knowledge may offer limitations, which need to be taken into consideration. 
PCR methods for detecting NoVs rely on detection of specific genomic material to establish the 
presence of virus in a sample. The genomic material detected by this method may or may not originate 
from an infectious virus particle. Therefore the number of genome copies detected by quantitative 
real-time PCR procedures may not relate directly to the number of infectious virus particles (Jofre and 
Ba, 2009). There is now clear evidence that real-time PCR methods can overestimate the number of 
infectious viruses (demonstrated with viruses other than NoV) present in environmental samples such 
as treated wastewater (Jofre and R., 2009). This will also undoubtedly apply to shellfish samples. This 
may be particularly true where the virus has been subjected to significant environmental pressures 
including wastewater disinfection before and during uptake by shellfish. This clearly leads to the 
potential to overestimate the infectious risk associated with NoV positive shellfish. Attempts have 
been made to establish a relationship between the number of infectious virus particles and the number 
of virus genome copies detected by quantitative PCR using a statistical (Donia et al., 2009) or 
methodological basis (Rodriguez et al., 2009). However these have been inconclusive or are 
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impractical for standardised routine use. Furthermore the situation is complicated by the fact that the 
ratio of infectious to non-infectious virus particles detected is likely to vary from sample to sample 
depending on the impact of the environmental conditions encountered (Jofre and R., 2009). In 
addition, the ratio between infectious and non-infectious virus particles increases over time from the 
initial release from the host (de Roda Husman et al., 2009). When considering what is an acceptable 
level of NoV in oysters it is important to realise that the infectious risk associated with low level 
positive oysters as determined by real-time PCR may be overestimated (See also Chapter 2). 
The current test procedures being presented for standardisation employ primers used to target NoV GI 
and GII individually (Lees and CEN WG6 TAG4, 2010). This is because it is not possible to develop a 
single set of primers cross-reactive for both genogroups. The primers employed detect a 
comprehensive range of genotypes within each of the genogroups but do not distinguish between them 
without further genotyping analysis. Each primer set will detect a range of NoV GI or GII genotypes 
and the level determined for each genogroup is the cumulative total of all genotypes detected. 
Therefore the current arrangement of reporting of values for NoV GI and GII levels individually is an 
artefact of the testing methodology. This, aligned with the fact that illness associated with oyster 
consumption can cause infection with multiple NoV genotypes (Gallimore et al., 2005; Kageyama et 
al., 2004; Le Guyader et al., 2008; Le Guyader et al., 2006b; Nakagawa-Okamoto et al., 2009; Sugieda 
et al., 1996), appear to make it most appropriate to base a standard on the total level of NoVs (both 
NoV GI and GII) present. 
A further possible important consequence of not distinguishing between genotypes is that different 
genotypes and associated variants may demonstrate differing infectious doses and susceptibility rates 
in the human population. Those genotypes with lower infectious doses and emerging GII.4 variants in 
particular, may present a greater risk of infection which is not specifically identified by the current 
PCR procedures. 
3.4. Sampling strategy 
Currently there is no guidance on sampling regimes for NoV monitoring in oysters or any other 
bivalve mollusc species. The sample size depends on the aim of the study, the anticipated prevalence 
and desired accuracy. For monitoring of NoV in bivalve molluscs, a relevant approach could be to 
determine whether contamination is present above a particular level, in order to prevent highly 
contaminated bivalves to reach the market with possible adverse health outcomes for the consumer. 
One could assume that for such monitoring, a standard method for detection of NoV in bivalve 
molluscs (e.g. oysters) based on PCR as described above is applied (Lees and CEN WG6 TAG4, 
2010). 
Table 2 shows the estimated probability that contamination will be detected when one sample is 
collected from a batch, and examined according to the CEN method, assuming that digestive tissues 
from 10 oysters are pooled, 2 g is used for nucleic acid extraction and RT-PCR is done on the 
concentrate and 10-fold diluted RNA, in duplicate. Results show that the success of the considered 
testing regime strongly depends on the NoV prevalence (batch prevalence), and the NoV concentration 
(genome copies per gram of digestive tissue) (Table 2).  
Relating these estimates to survey data depicted in Figure 1 for the UK, and assuming for illustration 
purposes that this sampling is representative for a batch, gives an estimated probability of detecting 
contamination of at least 39% (batch prevalence ~30%, concentration of ≥100 genome copies) for 
November 2009. For December 2010, the batch prevalence was about 60% for a concentration of 
≥500 genome copies, giving a detection probability of >93%. Examining more samples per batch 
would increase the probability of detecting any contamination. 
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Table 2:  Probability of identifying a random sample from a batch positive when processed 
according to the CEN procedure (pool of 10), as function of the batch prevalence and concentration 
(genome copies of NoV per g digestive tissue).  
NoV  prevalence
in batch 1 100 200 500 1000
1% 0.1% 4.0% 6.3% 8.9% 9.5%
2% 0.1% 7.6% 12% 17% 18%
5% 0.2% 17% 26% 37% 40%
10% 0.3% 27% 43% 61% 65%
25% 0.5% 39% 62% 88% 94%
50% 0.5% 41% 66% 93% 99%
75% 0.5% 41% 66% 93% 100%
95% 0.5% 41% 66% 93% 100%
Average concentration per g  digestive tissue
 
The estimated probability that contaminated batches remain unnoticed is 1 minus the detection 
probability from Table 2. As indicated, the fraction that passes the screening could theoretically be 
large, but this depends on the prevalence of contamination within a batch. Limited data are available to 
support the assumption that NoV are homogeneously distributed in a batch. However, Lowther (2008) 
showed little between animal NoV titre variability in C. gigas grown in commercial oyster sacks, 
which supports the assumption that oysters are exposed to uniform NoV contamination levels. In that 
case, the NoV prevalence in batches can be expected to be large, increasing the detection probability 
based on a single sample screening. If more quantitative data become available on individual oysters 
and batches, the theoretical estimates from Table 2 could be more refined.  
These estimated detection probabilities from Table 2 are dependent on the detection efficiency. The 
minimum number of oysters required for testing within the CEN protocol is 10 oysters. Usually 
oysters are tested in pools of 6 to 10 animals. Under controlled experimental conditions, analysis of 
pooled samples did not adversely affect NoV results (Rangdale, 2007). However, there may be an 
increased sensitivity of virus detection by analysing oysters individually compared to pooled samples 
(de Roda Husman et al., 2007). The lower the virus concentration or number of positive individuals 
per pool, the more false negative test results will be obtained when samples are analyzed in pools, as 
compared with individually analyzed oysters. 
Sample variability was evaluated by Le Guyader et al. in 2009 who analyzed six naturally 
contaminated shellfish samples three times in separate experiments using an elution precipitation 
method to concentrate viral particles from digestive tissues. Nucleic acids were then extracted using 
the Nuclisens kit (BioMerieux, France). NoV were detected by a one step rRT-PCR assay targeting the 
5' end of the ORF2 of NoV GI and GII in separate runs. Persistence of inhibitors were checked for 
both genogroups and are expressed as rRT-PCR efficiency percentage (Le Guyader et al., 2009).  
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Table 3:  Reproducibility for NoV detection in six naturally contaminated samples extracted three 
times each. 
Sample NoV GI rRT-PCR Assay (RNA/g DT) NoV GII rRT-PCR Assay (RNA/g DT) 
 efficiency a,b 1 2 3 efficiency a,b 1 2 3 
1 97.0 ±1.7 330 +QL - 100.7 ± 0.6 16 43 38 
2 95.6 ± 2.5 - - - 100.9 ± 2.6 - - +QL 
3 94.8 ± 4.3 - - - 98.2 ± 5.2 - - - 
4 96.7 ± 1.9 - - 250 102.4 ± 0.3 110 +DL 88 
5 97.6 ± 1.7 840 - - 99.7 ± 3.9 190 58 - 
6 94.8 ± 5.0 910 - - 100.1 ± 1.8 110 +DL 53 
a:  rRT-PCR efficiency was calculated based on co- amplification of GGI and GGII RNA IC with pure and one log dilution 
nucleic acid extract, and expressed in %. 
 b:   GGI or GGII NoV concentration was calculated based on Ct values obtained for pure and one log diluted NA and 
corresponding standard curve.  
+QL: positive sample but too close to the quantification limit. 
-:   below the limit of detection. 
 
None of the samples showed significant evidence of inhibition (% of rRT-PCR efficiency varied from 
89 to 99.6 for GI and 92.17 to 103.7 for GII). No GI NoVs were detected in any of the three replicates 
for two samples, while one or two of the replicates were positive for the other four samples. In 
contrast, all replicates gave the same result for four samples (one negative and three positive) in the 
GII NoV assay, and the other two samples had one or two replicates positive. These results suggest 
that either there is a heterogeneous distribution of virus within naturally contaminated samples or that 
the variability is due to the presence of very low concentrations of virus, as demonstrated by the 
detection of positive samples that were too close to the limit of detection for quantification (Le 
Guyader et al., 2009).  
Considering these data, the same approach was used to analyse shellfish linked to an outbreak (Le 
Guyader et al., 2010). Following epidemiological investigations, shellfish were collected in the 
caterer, producer, and the harvesting area.  
Table 4:  NoV quantification in oysters implicated in an outbreak. 
Sample Date Mean extraction 
efficiency (%)a 
Number of Positive 
Replicates/Number analysed 
NoV GII geometric mean 
concentration (range) b 
Caterer 02/13 16.1 3/4 229 (48-2548) 
Producer 02/14 13.7 2/3 144 (63- 273) 
Harvesting area 02/25 12.9 4/4 301 (35- 913) 
Harvesting area 03/05 12.6 4/4 776 (273-1885) 
a Mean percentage of mengovirus RNA copy number recovered in shellfish extracts relative to the amount of mengovirus 
added to samples prior to extraction. 
b Geometric mean concentration of positive samples expressed in RNA copies per g of DT (range of concentrations 
detected), before (uncorrected) and after (corrected) correction for the mean extraction efficiency.  
 
Samples were extracted four times (except a sample collected from the producer which was extracted 
only three times due to the limited number of oysters available) for quantitative analyses. Extraction 
efficiencies, as measured by recovery of mengovirus seeded into the shellfish prior sample processing, 
ranged from 12 to 16% for all extracts (Table 4). The measured NoV concentrations for caterer and 
producer were quite variable, ranging from negative to thousands of RNA copies per gram of DT 
(Table 4). The two other samples showed a more homogenous contamination for all replicates 
analyzed (all four replicates positive). The geometric mean virus concentrations for all of these 
samples were quite similar (Le Guyader et al., 2010). There is still a paucity of data on variation of 
contamination of naturally-contaminated oysters, but these data showed evidence of variability in 
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contamination. More information is needed on variability of oyster NoV level when exposed to the 
same contamination event. 
Under the current European control measures, shellfish harvesting areas are classified depending on 
the level of faecal contamination as judged by E. coli monitoring. To establish a sampling programme 
for this purpose a survey of faecal pollution inputs must be undertaken. Representative sampling 
points for the E. coli monitoring programme are then selected on the basis of this sanitary survey. 
European guidelines exist for conducting sanitary surveys. The information contained in the sanitary 
survey report should identify the source of human contamination impacting on harvesting areas. 
European regulations do not require that the information collected by the sanitary survey is used other 
than to determine the location of sampling points during routine bacteriological monitoring. However 
it has been proposed that this information can form the initial basis for assessing the likely extent of 
NoV contamination of oysters in a harvesting area (Pommepuy and Le Guyader, 2008). On the basis 
of the findings of a sanitary survey, combined with some background NoV monitoring, it is suggested 
that harvesting areas could be characterised for the relative risk of NoV contamination. This 
assessment combined with known seasonal and event based risk factors can be used to form a relative 
assessment of the likely extent of NoV contamination in harvest area. The major risk factors 
associated with NoV contamination of oysters are season, with winter identified as a high risk period, 
community outbreaks of gastroenteritis, and overflows of untreated wastewater associated with high 
rainfall events (Pommepuy and Le Guyader, 2008). An assessment based on these factors could be 
used to target NoV monitoring to at risk areas and highlight when management interventions may be 
required to protect public health. 
4. Data on NoV in oysters 
4.1. Prevalence studies 
There are very limited published studies on quantification of NoV in oysters determined by real-time-
PCR. Data presented on the following tables is only presence/absence data. 
Table 5:  Prevalence data on NoV from shellfish commercial areas (From publications later than 
2000) 
Country Shellfish No. samples No. of positive 
samples 
Method Reference 
USA Oysters 45 9 (20%) RT-PCR and hybridization (Costantini et al., 2006)
Japan Oysters 191 17 (9%) rRT-PCR, typing and sequencing (Nishida et al., 2003) 
Japan Oysters 483 33 (6,8) rRT-PCR, typing and sequencing (Nishida et al., 2007) 
UK Oysters 146  83 (56.8) rRT-PCR (Lowther et al., 2008) 
Ireland Oysters 119 37 (31%) rRT-PCR (only NoV GII) (Flannery et al., 2009) 
France Oysters 78 11 (14%) rRT-PCR Ifremer 20099  
Dutch Mussels (local) 21 1 (16.6%) Nested RT-PCR (Boxman et al., 2006) 
Spain Clams, cockles, 
mussels 
24 11 (45.8%) rRT-PCR (Vilarino et al., 2009) 
Italy Mussels, clams 120 10 (8%) rRT-PCR (Suffredini et al., 2008)
 
                                                     
9  Ifremer, Rapport annuel Laboratoire de Microbiologie- Département Environnement Microbiologie et Phycotoxine, 2009, 
50 pages. www.ifremer.fr/nantes/environnement.htm 
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Table 6:  Prevalence data on NoV from Shellfish at retail (market) (From publications later than 
2000) 
Country Shellfish No. 
samples 
No. of positive 
samples 
Method Reference 
Switzerland Oysters (imported) 87 8 (9.4%) RT-PCR capsid (GI) pol (GII) (Beuret et al., 2003) 
Hong Kong Oysters (imported) 507 53 (10.5%) RT-PCR and sequencing (Cheng et al., 2005) 
UK Oysters 66 39 (59%) rRT-PCR (Lowther et al., 2010) 
Dutch Mussels (imported) 21 6 (28%) Nested RT-PCR (Boxman et al., 2006) 
Italy Clams, mussels, 
oysters 
116 14 (12.1%) Nested RT-PCR (NoV GII) 
and sequencing 
(Terio et al., 2010) 
USA Gulf oysters 380 15 (3.9%) rRT-PCR (Depaola et al., 2010) 
 
A few studies have been conducted on shellfish collected from the market. Prevalence data in general 
is difficult to compare, as methodologies used are not the same in different studies. However it is 
interesting to note that prevalences obtained in market product are comparable to these observed in 
commercial harvesting areas. 
Most of the studies reported about 10% of oysters sampled being contaminated by NoV; except in the 
UK with prevalences above 50%. Contamination of Irish oysters was detected in about 31% , but only 
the presence of NoV GII was analyzed, so this prevalence may be higher for total NoV.  
4.2. Quantitative data from outbreaks 
Table 7:  Oysters implicated in outbreaks, quantification 
Date NoV GI concn* NoV GII concn No Consu-
mers 
No. Sick 
people 
No. stool 
samples
Genotype present in stool Reference 
23/03/2000 GI.1: 85-237 <DL 4 4  GI.1   (Le Guyader et al., 
2003) 
19-24/12/2002 GI.4: <QL GII.4: 25-125 36 
- 
21 
202 
12 
41 
GI.4, GII.4 & GII.b 
GI.4, GI.6, GII.4 & GII.8 
(Le Guyader et al., 
2006a) 
08/02/2006 GI: 72-130 <DL 2 2 2 GI.1, GI.2, GII.2 (AiV, AV) (Le Guyader et al., 
2008) 
15-17/02/2006 GI.1: 5000-16000 GII.4 1600-2500
GII QL 
77 37 4 GII.7, GII.b (AiV) (Le Guyader et al., 
2008) 
18/02/2006 GI 2300 
G1.2: 610-2300 
GI: 260-880 
GII: <QL 
GII.4: 1100 
GII.4: LQ-79 
  6 GI.1, GI.2, GI.4, GII.4, 
GII.7, GII.17, GII.B (AiV, 
EV, AV, RV) 
(Le Guyader et al., 
2008) 
05/02/2008 <DL GII.4: 48-2548 34 23 5 GII.4, GII.2 SaV G1.2 (Le Guyader et al., 
2010) 
01/2007/- 
05/2010 
795 
30 
nd 
35 
139 
22 
1550 
2175 
8215 
695 
13 
208 
 54 
5 
89 
115 
4 
20 
 GI & GII 
GII 
GI 
GI & GII 
Unknown 
Unknown 
(Lowther et al., 
2012) 
 
05/02/2010 <100 1736 30 11 2 GI , GII (Baker et al. 2011) 
18/02/2010 <DL & 42 2040 & 2350  >70 2 GII.13 Marine Institute 
Ireland10 
* expressed as number of RNA copies/g of DT.  
Bold and italics: left over from the consumer fridge, bold: same sequence detected in shellfish and stool samples 
QL: quantification limit, DL: detection limit 
Blank : no data available 
AiV: Aichivirus, EV: enterovirus, AV: astrovirus, RV: rotavirus, SaV: sapovirus 
                                                     
10www.marine.ie/home/services/operational/ShellFish/Investigation+into+an+outbreak+of+gastroenteritis+associated+with+
a+shellfish+harvesting+area.htm 
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Detection and quantification of viral pathogens in shellfish became more reliable with the 
development of molecular methods, the use of rRT-PCR, and the inclusion of quality controls has 
made possible sample to sample comparisons. Controls are important to be confident that 
concentrations expressed reflect correctly the amount of viruses present in the contaminated oysters. 
Several publications report the frequent implication of NoV GI strains in oyster related outbreaks 
(Gallimore et al., 2005; Kageyama et al., 2004; Nakagawa-Okamoto et al., 2009). If we consider data 
presented in Table 7, it is evident that very low values of NoV genome copies/g may be linked to 
human cases. It is also apparent that in several outbreaks investigated the values of NoV genome 
copies/g has been above 500.   
Considering these restrictions, it can be concluded that NoV concentrations detected in oysters linked 
to human cases varied greatly from less than hundred copies to more than ten thousand. The 
contamination of an oyster with multiple NoV strains complicates the investigations further. When 
stool samples are analyzed, variability is observed as different individuals may be infected by different 
strains present in the consumed oyster (Baker et al., 2011; Le Guyader et al., 2008). The genetic 
susceptibility of exposed consumers is an important factor, and may explain some variations in 
consumer illness (Le Guyader et al., 2010). There are two recognized mechanisms involved in 
resistance to NoV infection: genetic factors and acquired immunity. It was shown that NoV binds to 
histoblood group antigens (HBGAs) (Hutson et al., 2002; Marionneau et al., 2002) and the binding 
pattern varies between genotypes (Tan and Jiang, 2010). Thus it is likely that every person is 
genetically susceptible to one or more NoV genotypes (Atmar, 2010). Acquired immunity is the other 
resistance mechanism, even if this immunity is not long lasting (Atmar, 2010).   
Considering data from outbreaks and the diverse factors that interfere with NoV infection we cannot 
conclude on a reliable safe limit for oyster contamination. 
4.3. Quantitative data from field studies 
4.3.1. United Kingdom 
The UK data was generated from a Food Standards Agency funded study conducted during 2009-
201111 . The study was organised and all analysis performed at the Cefas Weymouth laboratory using 
a method accredited to ISO 1702512. The study aimed to generate unbiased data on NoV occurrence in 
UK oyster production areas therefore a representative selection of sites were chosen on the basis of a 
risk assessment using factors including classification history, population in adjacent areas, previous 
association with outbreaks, etc. All sites sampled were designated and classified under EU Regulation 
854/200413 and thus available for commercial production. Classifications ranged from class A to class 
C.  A cross selection of 39 study sites was chosen representing low, medium and high risk according 
to the risk matrix criteria. Undepurated oysters from 39 study sites from around the United Kingdom 
were sampled monthly between May 2009 and April 2011 and despatched in temperature controlled 
conditions to the Cefas laboratory. Oysters were tested for the presence of GI and GII NoV RNA using 
a rRT-PCR method based upon the CEN TAG4 draft standard. Briefly, 2g of oyster digestive tissues 
were treated with proteinase K solution, RNA was then extracted from 500ul of oyster homogenate 
using proprietary magnetic silica reagents and each sample RNA was subjected to rRT-PCR using 
primers and probes as described in (Le Guyader et al., 2009), excepting the GI probe which was as 
described in (Hoehne and Schreier, 2006). 
                                                     
11 www.food.gov.uk/science/research/foodborneillness/microriskresearch/p01programme/p01projlist/p01009/ 
12 www.iso.org/iso/Catalogue_detail?csnumber=39883 
13 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:226:0083:0127:EN:PDF 
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Figure 1:  NoV occurrence in UK oyster samples 
Of 857 samples tested, 844 (98.5%) provided valid results for NoV GI and GII. NoV was detected in 
76.2% of samples, with 47.6% being positive for both NoV genogroups, 20.9% being positive for GI 
only and 7.7% positive for GII only. Similar NoV prevalences were found in both species of oyster 
tested. NoV prevalence varied from month-to-month ranging from a minimum of 45.7% samples 
positive in September 2010 to a maximum of 100% positive in February 2010. A strong winter 
seasonality was observed with 90.0% of samples taken between October and March positive compared 
with 62.4% of samples taken between April and September. Quantification of positive samples 
revealed that the majority were below the limit of quantification (100 detectable genome copies/g 
digestive tissues) for both genogroups. However a number of samples contained levels in excess of 
10,000 copies/g – for NoV GI the maximum recorded quantity was 16,507 copies/g and for GII it was 
18,024 copies/g. All 39 sites tested provided at least one NoV positive result, although prevalence 
varied from 21% to 100%. NoV levels varied markedly between sites with some sites scoring 
consistently over 1,000 copies/g during the winter while others rarely or never exceeded 100 copies/g. 
As with prevalence, average quantities varied markedly between seasons, with highest levels detected 
between December and March. The scores for NoV GI and GII in individual samples were 
significantly correlated with each other, however results for NoV GII tended on average to be higher 
than those for GI. Overall 63.5%, 85.4% and 98.9% of oyster samples were under 100, 1,000 and 
10,000 genome copies per g respectively. 
4.3.2. Ireland 
The Irish data was generated from harvesting area monitoring conducted by the Marine Institute which 
is Irish National Reference Laboratory for bacteriological and virological monitoring in bivalve 
shellfish. Data was generated from ad hoc testing conducted in response to requests from producers 
(additional quality assurance purposes) and the competent authority in Ireland (problematic harvest 
areas). A total of 113 samples from 11 different harvesting areas were tested from January 2009 to 
January 2011. The areas tested ranged from good quality category A areas through to category B area. 
Two of the harvesting areas tested had been previously associated with gastroenteritis illness 
following consumption of oysters. Therefore it must be recognised that the data provided here is 
limited and may not be fully representative of levels of NoV found in oysters from Irish harvesting 
areas. Oysters were tested for the presence of GI and GII NoV RNA using a rRT-PCR method based 
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upon the CEN TAG4 draft standard. Briefly, 2g of oyster digestive tissues were treated with 
proteinase K solution, RNA was then extracted from 500ul of oyster homogenate using proprietary 
magnetic silica reagents and each sample RNA was subjected to qRT-PCR using primers and probes 
as described in (Le Guyader et al., 2009), excepting the GI probe which was as described in (Hoehne 
and Schreier, 2006). The test method was accredited to ISO 17025 for use in the Marine Institute from 
September 2010. 
 
 
Figure 2:  NoV occurrence in Irish oyster samples 
The limited data set presented for Irish harvesting area is probably affected by a sampling bias and is 
skewed towards more problematic harvesting areas (areas associated with illness and higher 
contamination levels). Therefore the data probably represents a worst case scenario of levels of NoV 
found in Irish oyster harvest areas and conclusions from the data should be treated with caution. Both 
the frequency of occurrence and level of NoVs present were clearly seasonal with higher levels 
detected during the winter period. During the months of November through to March 88.1% of the 
oysters tested contained NoVs with mean level of 1328.9 genome copies per g compared 50.9% 
containing NoVs and mean levels of 213.4 genome copies per g in the remaining months of the year. 
During the winter months (Nov-March) 32.1% of oysters samples contained levels of NoV over 1,000 
genome copies g (max Value 10,000) with NoVs absent in just 11.3% of samples. During the same 
winter period 30.2%, 52.8% and 68.0% of oyster samples were under 200, 500 and 1,000 genome 
copies per g respectively. 
4.3.3. France 
The French data was generated between January 2009 to February 2011. A total of 1,036 samples 
were analyzed with an average of 40 samples per month. These samples were collected through 
different ongoing research project in the laboratory and also as part of the French National reference 
laboratory activity, and therefore may not be representative of the overall situation in France. Each 
sample, collected from various locations along the coast of France, was constituted by at least 12 
oysters. The method used, based on the CEN method, includes a concentration step by polyethylene 
glycol before nucleic acid extraction using the Nuclisen kit (BioMerieux). Extractions efficiencies 
were evaluated by using a virus control (Mengo virus) and only samples with an extraction efficiency 
above 10% were considered. Absence of inhibitors was checked by testing samples in duplicates and 
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after one log dilution. If all controls were verified then concentration was calculated using standard 
curves and taking into account extraction efficiency (Le Guyader et al., 2009). 
 
Figure 3:  NoV occurrence in French oyster samples 
A clear impact of season on shellfish contamination was observed, mirroring virus discharged by 
human population into sewage. Interestingly some contamination may be observed in August or June 
possibly due to local events. The seasonal impact of contamination, linked to an increase of virus in 
sewage correlates also with the finding that oysters are more likely to accumulate virus during winter 
months based on ligand analysis (Maalouf et al., 2010a). Also climatic events such as important 
rainfall are more likely to occur during January to April, increasing the risk of sewage input into 
coastal environment (Maalouf et al., 2010a). 
4.3.4. Compliance scenarios 
It is important to recognise that the surveillance data available from the different Northern European 
countries (Ireland, UK, France) may not be directly comparable. The UK study was designed to 
systematically sample a cross selection of commercial harvest areas and therefore can be considered to 
be representative of the UK situation. In comparison the data from Ireland and France was generated 
from studies with different objectives and may not be fully representative. Data from Ireland, for 
example, may over represent the extent of contamination, since at risk areas (e.g. areas associated with 
outbreaks) were preferentially sampled. Nevertheless it is clear that common findings emerge from 
these studies: (i) NoV was found in samples from all countries using the standardised CEN methods 
demonstrating their robustness; (ii) all the studies reveal a surprisingly large overall sample positivity 
rate; (iii) a strong winter seasonality for NoV contamination was observed in all the countries; (iv) the 
titres of NoV found in samples showed a similar range in all countries (<100 to 10,000 RNA copies 
per gram); (v) a standard based on virus absence (not detected by the CEN method) would have a high 
impact in all of the countries for which data was available.   
It is clear that samples containing no detectable NoV can be considered to present the lowest level of 
consumer risk. However, the above surveillance studies illustrate the high impact of a standard, or 
microbiological criteria, based on simple absence of virus. There is now emerging evidence of a NoV 
RNA dose/illness relationship (dose response) both from human volunteer studies, from oyster 
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consumption studies, and from observation of titres found in outbreak samples (section 2). However, it 
is also the case that illness risk from very low levels of NoV cannot be excluded. Consequently it is 
not currently possible to determine a ‘safe’ quantitative risk threshold for NoV RNA with the available 
data. It is however possible to illustrate the impact (for sample failure) of different possible NoV 
compliance regimes. This can help to inform the risk management decision process. The available 
surveillance data (from the above studies) was further analysed to illustrate the impact of different 
possible NoV levels that could conceivably be set in a food standard or criteria (Table 8). 
Table 8:  Average percentage of samples that would fail during the high risk season (January to 
March 2010) if a maximum limit of 100, 200, 500, 1000, or 10,000 genome copies/g were set 
 100 c/g 200 c/g 500 c/g 1,000 c/g 10,000 c/g 
United Kingdom 65.6% 61.1% 46.9% 37.2% 2.7% 
Ireland 83.3% 83.3% 72.2% 44.4% 11.1% 
France 33.6% 24.4% 10.0% 7.7% 0% 
 
It is clear that a production area NoV standard at the low end of the possible range (100 RNA 
copies/g) would have a high impact in all countries for which data was available (33-83% of samples 
non-compliant on average). It should also be remembered that this is highly seasonable in all 
countries, with sample failure potentially reaching near 100% during peak at risk periods (e.g. in the 
UK). By contrast, compliance during the summer low risk period may be much higher (e.g. >90% in 
France). Intermediate possible standards (e.g. 200 or 500 RNA copies/g) would have an intermediate 
impact. At the other extreme a comparatively high virus standard (e.g. 10,000 copies per gram) would 
have a relatively small impact on sample non-compliance (e.g. <2.7 % in the UK). In considering the 
risk management options it should be remembered that all of the areas studied in all countries were 
commercial production areas or monitored recreational harvest areas compliant with the 
microbiological standards in current EU legislation.  Thus introduction of any of the possible range of 
virus standards illustrated in Table 8 would have a beneficial health impact over the current situation. 
5. Post-harvest interventions to control NoV in oysters 
5.1. The effect of depuration and relaying on NoV levels 
Depuration is a commercial processing option for the treatment of oysters that is widely used 
worldwide. During depuration oysters are placed in tanks of seawater in an attempt to flush or purge 
faecal contaminants from the oysters. However, studies in both laboratory and commercial settings 
have shown that depuration times and conditions currently used are inadequate to remove viruses 
despite the rapid removal of bacterial pathogens and indicator organisms (Lees, 2000; Richards et al., 
2010).   
Depuration has frequently been demonstrated to be capable of rapidly eliminating E. coli in laboratory 
and commercial studies (Lees, 2000; Richards et al., 2010). However, numerous studies either directly 
investigating pathogenic viruses or virus indicator organisms have demonstrated minimal reductions in 
virus levels during depuration. Specifically, a number of studies have demonstrated the failure to 
eliminate NoV from oysters following depuration. NoV persistence was demonstrated in oysters 
responsible for outbreaks which had been depurated for several days and were compliant with E. coli 
standards (Le Guyader et al., 2008). Human pathogenic viruses including NoV were detected at the 
same frequency in oysters before and after commercial depuration in four European countries 
(Formiga-Cruz et al., 2002). Similarly, different shellfish samples (mussels, clams, oysters) collected 
in Italy showed no significant difference in the frequency of NoV contamination between depurated or 
non-depurated samples (Savini et al., 2009). Therefore NoV persistence in oysters following 
depuration as widely practiced in the EU has been demonstrated. 
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Despite the demonstrated persistence of NoVs in depurated oysters there is very limited data directly 
quantifying the extent of any NoV reduction during depuration. Following bioaccumulation of NoV 
GI.1 in oysters and subsequent depuration for 48h in a laboratory setting no significant change in virus 
titers were observed (Schwab et al., 1998). More recently, quantitative real-time PCR procedures have 
been applied to depuration studies. In a laboratory-based study using Crassostrea gigas that had been 
bioaccumulated with NoV GII.4 and then depurated for 23h hours no significant reduction in virus 
levels were observed (McLeod et al., 2009). Some oyster species may behave differently regarding 
NoV reduction during depuration. For example NoV GI.1 persisted for up to 29 days in Crassostrea 
ariakensis and 22 days in Crassostroea virginica (Nappier et al., 2008). Specific retention of NoV was 
observed by (Ueki et al., 2007) with no decline of NoV genomic copies in artificially contaminated 
oysters after depuration for 10 days whereas feline calicivirus could not be detected after 3 days. It has 
been demonstrated that some NoV genotypes bind to glycan ligands in the digestive tissue of oysters 
and may account for the inefficiency of depuration practices (Le Guyader et al., 2006b; Maalouf et al., 
2010b). These glycan ligands are very similar to human histo-blood group antigen (HBGA) 
carbohydrates found in humans. A few studies have reported a limited reduction of NoV during 
depuration under different purification conditions. One study demonstrated almost a one log reduction 
in the levels of a NoV GI genotype in environmentally contaminated oysters following depuration for 
3 days at 20ºC whereas no reduction was observed over the same period in oysters held at 9ºC 
(Henshilwood et al., 2003). During commercial depuration initial levels of 492 NoV genome copies 
per g were reduced by 72 % after 4 days and to <100 genome copies/g in 6 days at 17ºC (Dore et al., 
2010). 
It has been demonstrated that for viruses other than NoVs, factors such as the initial contamination 
level, depuration time, depuration system, physiological state of the shellfish, seasonal conditions, 
time, water temperature and salinity have an influence on the depuration dynamics of viral 
contaminants (De Medici et al., 2001; Dore and Lees, 1995; Kingsley and Richards, 2003; Lees, 
2000). In particular depuration at elevated temperatures for extended periods has been shown to 
increase the extent of virus removal following depuration. However despite the limited data presented 
above this has not been fully demonstrated for NoVs. There is a clear requirement for further 
investigation to determine the full extent of NoV reduction that can be achieved under such depuration 
regimes. 
An alternative treatment to depuration is relaying (Lees, 2000). This involves transferring sewage-
contaminated oysters to pollution free marine environments and allowing them to purge sewage 
derived contaminants under natural environmental conditions. A limited number of studies have 
investigated virus removal during relaying. In studies using viruses other than NoVs, relaying has 
demonstrated differential reductions of viruses levels in oysters. Humphrey and Martin (1993) 
reported that FRNA bacteriophage were not detected after 2 to 3 weeks of relaying while somatic 
coliphages were still detected after 5 weeks. Rotavirus-like particles (VLPs) could be detected up to 37 
days of relaying when an initial concentration of 105 VLPs/oyster was present (Loisy et al., 2005). As 
with depuration, seawater temperature appears to be an important factor in virus removal. Using 
FRNA bacteriophage, Dore et al., in 1998 demonstrated virus clearance after two weeks and 
persistence after 4 weeks in two difference relaying cycles at the same location. The authors suggest 
that seawater temperature was responsible for the difference between the two cycles.  
Critically the usefulness of relaying as a treatment to reduce NoVs depends on the persistence of NoVs 
in oysters in the marine environment. Data specifically relating to NoV persistence in oysters 
following contamination events are still rare. After a flooding event that contaminated a production 
area in southern France, some oysters were implicated in cases of gastroenteritis in consumers. The 
Sanitary Authority closed the area, and virological analysis were conducted to evaluate NoV 
contamination (Table 9). 
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Table 9:  Detection and quantification of NoV in shellfish samples.  
Week No. samples Genogroup I  Genogroup II 
  No. pos. (%) Mean conc*  No. pos. (%) Mean conc*. 
1 17 10 (59) 6900  12 (70) 1300 
2 15 5 (33) 3100  3 (20) 120 
3 13 3 (23) 120  2 (15) DL 
4 17 7 (41) 220  3 (17) 200 
*: concentration expressed in RNA copies / g of digestive tissues.  
 
During the four weeks, contamination decreased slowly both in terms of number of positive samples 
or mean concentration. However four weeks after the contaminating event, viruses were still present 
(Le Guyader et al., 2008). Similar results were observed in Ireland when contaminated oysters which 
had been associated with outbreaks of illness were relayed in an area of clean seawater. The NoV GII 
contamination was reduced from 2900 to 492 copies /g of DT after 17 days relaying. NoVs were 
further reduced from 492 to 136 copies/g of DT in 4 days and <100 copies/g of DT in 6 days at 17ºC 
for NoV GII genotypes (Dore et al., 2010). These oysters were subsequently placed on the market with 
no reported cases of illness. 
It has been suggested that although long-term relaying may represent an effective treatment it may be 
impractical from a commercial standpoint because of increased production costs associated with the 
additional handling, it reduces product availability and also it may be problematic to find clean areas 
to perform relaying (Richards et al., 2010).     
All EU commercial bivalve mollusc production areas must be monitored on a periodic basis for E.coli 
as an indicator of faecal pollution. This monitoring determines a classification A (cleanest), B, or C 
(most contaminated). It is a legal requirement for molluscs harvested from class B and C areas to be 
subject to post-harvest treatment prior to placing on the market for human consumption (for details see 
EFSA 201114). Products harvested from class B areas may be treated by depuration, relaying or heat 
treatment. Products harvested from class C areas can only be treated by long-term relaying or heat 
treatment. A recent study by the EU Reference Laboratory 15 showed that about 50% of EU production 
areas fall into the class B category and thus require post-harvest treatment. For products placed live on 
the market (e.g. oysters) depuration (self-purification in tanks of clean seawater) is the predominant 
treatment process used. Thus depuration is very extensively used within the EU as a post-harvest 
treatment process for reduction of microbiological risk associated with bivalve molluscs. In EU 
regulations the distinction between treatments allowed for class B and class C products reflects a long 
standing concern over the adequacy of depuration for successful treatment of more highly 
contaminated products – in particular those potentially contaminated with enteric viruses. EU 
regulations set a microbiological standard of 230 E. coli (per 100g of shellfish flesh) for both class A 
production areas (can be harvested and directly placed on the market without further treatment) and 
end-products placed on the market following post-harvest treatment (Regulations (EC) No 854/2004 
and 2073/2005). The regulations further require post-harvest treatment measures (such as depuration) 
to be performed such that products placed on the market comply with the required 230 E. coli 
standard. Critical depuration treatment parameters, such as the time period for mollusc treatment in the 
tanks, is not specified by legislation but rather determined by the time required to secure compliance 
with the E. coli end-product parameter. Commercial systems are not optimised for virus reduction 
since the compliance target is based on E. coli removal. Indeed, in most EU Member States previous 
minimum purification time standards have now been replaced by reliance on operator compliance with 
E.coli criteria – with the result that depuration times are commonly much shorter. Short depuration 
                                                     
14  EFSA Panel on Biological Hazards (BIOHAZ); Scientific Opinion on An update on the present knowledge on the 
occurrence and control of foodborne viruses. EFSA Journal 2011;9(7):2190. [96 pp.] doi:10.2903/j.efsa.2011.2190. 
Available online: www.efsa.europa.eu/efsajournal 
15  Comparison of bivalve mollusc harvesting area classifications under EC Regulation 854/2004 across EU Member States 
(2009). Dated 11/4/2011. www.crlcefas.org. 
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times (e.g. <24 hours) are unlikely to be effective for removal of NoV. The dangers of reliance on E. 
coli criteria for regulation of key depuration parameters have been recently highlighted16. Now that 
robust and quantitative virus methods are available a much more effective strategy would be to require 
food business operators to validate their treatment processes (including depuration) against a NoV 
criteria. This would also be in conformity with the standard HACCP approach for operation of food 
processes. Removal of NoV to non-detectable using the standardised CEN methods would be likely to 
ensure a high level of consumer protection but may be difficult to achieve in practise. Alternative 
approaches would be to require removal to below a target level (Dore et al., 2010) suggested 200 
genome copies per gram) or to require a minimum percentage removal (e.g. 95%) throughout the 
depuration process. Reduction of viral load during the depuration process, even if complete 
elimination cannot be achieved, can be considered to have a beneficial health effect since recent data 
suggests that risk of infection is related to viral dose consumed (See section 2). Unfortunately it is not 
currently possible to set a standard based on the desired health outcomes since the supporting evidence 
is not available – thus a risk management decision would be required. 
In summary it is clear that commercial depuration as currently practiced cannot be relied upon as a 
control measure to effectively remove NoVs from oysters. The limited quantitative data available 
demonstrates that depuration at elevated temperatures for extended periods can reduce NoV levels in 
oysters by between 0.8 and 1 log10 (Dore et al., 2010; Henshilwood et al., 2003). Relaying combined 
with depuration at elevated temperatures has been demonstrated to achieve a reduction of greater than 
1.46 log10 (Dore et al., 2010). However genotype specific binding patterns may mean that meaningful 
reductions of NoVs during relaying and/or depuration may not be feasible for all NoV genotypes. 
There remains a clear need for further investigations to establish elimination patterns of NoVs from 
oysters during depuration and relaying regimes. 
5.2. Effects of other post-harvest treatments used in food processing on viruses 
NoV are quite persistent and are difficult to eliminate when in shellfish body. Usually to reduce 
viruses from any food product, cooking is the most efficient method. However, in shellfish, thorough 
cooking may change organoleptic characteristics, and home or restaurant cooking is generally 
inadequate for the elimination of NoV (Alfano-Sobsey et al., 2011; Richards et al., 2010).  
Studies to evaluate the thermal resistance of NoV is hampered by the lack of infectivity assay and 
different testing methods, different virus strains or surrogates, and different shellfish species may 
impact results. Total inactivation (5 log10) of MNV-1 was achieved in PBS after 3 min at 72°C (Wolf 
et al., 2009), but less thermal inactivation would be expected in viruses protected within shellfish 
tissues as for example boiling for 3 min gave an internal temperature of 92°C, and steaming for the 
same period gave an internal temperature of only 63°C (Richards et al., 2010). Canned oysters are 
likely to be safe from a virus standpoint, since the canning process provides sufficient heat to 
essentially sterilize the product (Richards et al., 2010).  Slomka and Appleton (1998) investigated the 
inactivation of feline calicivirus (FCV) by immersion of cockles in boiling water for 0.5 min and 
found 1.7 log10 reduction of FCV. At that time, the internal temperature of the cockles reached 
approximately 60°C. After 1 min, the internal temperature reached 78°C and FCV (initially 4.5 log10 
TCDI50/g present) could not be detected anymore. 
High pressure processing (HPP) has emerged as a potential treatment to inactivate viruses in shellfish 
(based on observation done for vibrios) and to facilitate oyster shucking. Commercial processors use 
around 275−300 MPa of pressure for about 3 min, keeping taste and texture of raw product, that 
remain plump and juicy, and have a slightly cooked appearance from partial denaturation of oyster 
proteins by the pressure treatment. In 2002, Kingsley and colleagues were the first to demonstrate that 
pressure of 250 MPa for 5 min was sufficient to inactivate 7 log10 of FCV in culture media containing 
                                                     
16 EFSA Panel on Biological Hazards (BIOHAZ); Scientific Opinion on An update on the present knowledge on 
the occurrence and control of foodborne viruses. EFSA Journal 2011;9(7):2190. [96 pp.] 
doi:10.2903/j.efsa.2011.2190. Available online: www.efsa.europa.eu/efsajournal 
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10% foetal bovine serum (Kingsley et al., 2002). However it was later demonstrated that food 
matrices, salt concentrations, pH, and temperature affect virus inactivation rates (Kingsley and Chen, 
2008). The advent of a quantitative assay for MNV-1, a closer relative of human NoV than FCV, led 
to a study showing a 4 log10 decrease in virus infectivity after pressure treatment of oysters for 5 min 
at 400 MPa (Kingsley et al., 2007), therefore, it was uncertain which surrogate was more 
representative of human NoV inactivation under high pressure. A human challenge study was 
conducted to assess the effectiveness of HPP to inactivate human NoV in oysters. Over 50 volunteers 
were challenged either with oysters that were inoculated into their stomach cavity with NoV GI.1 and 
pressure-treated or with oysters that were similarly inoculated with virus but were not pressure treated. 
Only oysters treated with 600 MP for 5 minutes at 6°C, were effective at inactivating NoV (no sick 
volunteer), but induced a mildly cooked whitish appearance, presumably not acceptable to consumers 
(Leon et al., 2011). Such study clearly demonstrate that human NoV in oysters is more resistant to 
HPP than either FCV or MNV-1, which again stresses the limited usefulness of studies involving 
surrogate viruses. It may also be possible that resistance may vary among the different genetic 
clusters.  
Enteric virus inactivation studies have included work on the effects of ultraviolet light and ionization 
radiation on virus levels.  Ultraviolet irradiation is effective in reducing NoV surrogates on the surface 
of product, but does not have penetrating power to inactivate viruses deep within the shellfish. 
Similarly, gamma irradiation at 0.5, 0.3, and 0.1 kGy produced 3 log10 decreases in FCV, canine NoV, 
and MS2 titers, respectively, in low protein solutions, but high amounts of protein appreciably reduced 
the effectiveness of ionizing irradiation (de Roda Husman et al., 2004).  
Freezing of shellfish is a potential processing method of limited value. Raw shellfish meats are often 
frozen to await subsequent processing, such as breading or cooking either at the restaurant or at home.  
Although freezing tends to preserve viruses, there can be an initial loss in virus titer with each freeze-
thaw cycle. That loss in titer may reduce virus levels in minimally contaminated product to enhance 
safety. Freezing by itself seems inadequate to protect the consumer from even lightly contaminated 
shellfish, but when freezing is combined with cooking or HPP, the additive effect of both processes 
would further enhance shellfish safety (Richards et al., 2010).   
Smoking is another commercial method of processing shellfish. There are various, non-standardized 
methods for smoking shellfish and the amount of heat applied in this process is likely to vary 
considerably from one facility to another and perhaps from one batch of shellfish to another. It is 
uncertain if smoking alone is effective in reducing virus levels in shellfish, but many smoked products 
are also canned, which provides sufficient heat to inactivate viruses (Richards et al., 2010). 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Answer to ToR 1: The use of real-time PCR as a means of detection and quantification of NoV in 
oysters. 
• PCR-based detection methods exist for NoV in bivalve shellfish. Harmonization and 
standardization are currently ongoing for NoV in shellfish under the auspices of the European 
Committee of Standardisation (CEN), and publication of methods is expected soon. 
• To achieve a good sensitivity separate assays are required for NoV GI and GII detection. 
• With the appropriate quality assurance measures, including accreditation and proficiency testing, 
the standardised CEN method is considered suitable for use for detection and quantification of 
NoV in oysters within a legislative context. 
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Answer to ToR 2: Limits that do not pose an unacceptable risk to consumers for NoV 
genogroups GI and GII in oysters as determined by real-time PCR. 
• NoV can be frequently detected by rRT-PCR in oysters during winter in European areas compliant 
with current legislative requirements (E. coli standards) for which data are available. 
• NoV is highly infectious. Exposure of human volunteers to serial dilutions yielded a dose-
dependent probability of becoming ill ranging from 0.1 (at a dose of 103 NoV genome copies) to 
0.7 (at a dose of 108 virus genome copies). However, there is no threshold infectivity limit for 
NoV detected by rRT-PCR. From outbreak published data, it can be concluded that NoV 
concentrations detected in oysters linked to human cases varied greatly from less than hundred 
copies to more than ten thousand per gram of material analysed. 
• The probability of becoming infected increases with the dose but depends also on the 
characteristics of the organism, the food matrix and the host factors. 
• The relationship between the number of infectious virus particles and the number of virus genome 
copies detected by quantitative PCR is not a constant, and may vary depending on environmental 
conditions including time from the initial release from the host. 
• The number of genome copies detected by quantitative PCR may not relate to infectious NoV 
particles, and as a consequence the method can only be used to provide an indirect measure of 
risk. 
• When considering what is an acceptable level of NoV in oysters it is important to realise that the 
infectious risk associated with low level positive oysters as determined by rRT-PCR may be 
overestimated. 
• Despite observed differences between the ability of NoV GI and GII to cause human infection via 
different transmission routes there is insufficient knowledge on the dose response for each 
genogroup to allow a distinction. Therefore it is appropriate to consider the total NoV load 
(GI+GII) when establishing microbiological criteria. 
• Quantitative data on viral load from areas compliant with current EU legislative requirements (E. 
coli standards) during January-March 2010  in 3 member states, show that a viral limit of 100, 
200, 500, 1000 or 10,000 NoV PCR genome copies would result in 33.6-88.9%, 24.4-83.3%, 10.0-
72.2%, 7.7-44.4% or 0-11.1% of non-compliant batches, respectively. 
• Compliance with any of the above NoV limits would reduce the number of contaminated oysters 
placed on the market and therefore the risk for consumers to become infected. The lower the limit 
the greater the consumer protection achieved. However, it is not currently possible to quantify the 
public health impact of establishment of different limits.    
• Microbiological criteria for NoV in oysters are useful for validation and verification of HACCP-
based processes and procedures, and can be used to communicate to food business operators and 
other stakeholders what is an acceptable or unacceptable viral load for oysters to be placed on the 
market. 
• Microbiological criteria for NoV in oysters could also be used by competent authorities as an 
additional control to improve risk management in production areas, during processing and retail. 
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Answer to ToR 3: Treatment regimes (post-harvest interventions) that can be relied upon to 
reduce NoV counts in oysters 
• Current treatment regimes for products placed live on the market (depuration and relaying) as 
commonly practised do not effectively reduce NoV in oysters. 
• Depuration and relaying may be improved by optimising process parameters to enhance NoV 
reduction (e.g. depuration times, water temperature). However, limited data is currently available. 
• Alternative treatments such as commercial heat treatment and high pressure may be effective for 
NoV inactivation, but give rise to organoleptic changes which may be unacceptable to consumers. 
• The most effective public health measure to control human NoV infection from oyster 
consumption is to produce oysters from areas which are not faecally contaminated, particularly 
given the ineffectiveness of current control regimes. 
RECOMMENDATIONS 
• Control measures for NoV in oysters should focus on avoiding contamination by either preventing 
human faecal contamination in mollusc production areas, or restricting commercial harvesting 
from faecally contaminated areas. 
• On the basis of the data presented in this Opinion, risk managers should consider establishing an 
acceptable limit for NoV in oysters to be harvested and placed on the market. 
• Competent authorities should consider the use NoV testing of oysters (standardized CEN method) 
to verify compliance with the acceptable NoV limit established. 
• Food business operators should consider incorporating NoV testing of oysters (standardized CEN 
method) to verify their HACCP plans to demonstrate compliance with the acceptable level. 
• The quantitative levels of NoV within production areas and batches should be investigated further, 
in order to optimise sampling strategies.  
• Sampling schemes to comply with NoV criteria should be risk based, e.g. considering seasonality, 
faecal pollution levels, community outbreaks, and variability from year to year. 
• An EU-wide baseline survey on NoV contamination in oysters should be considered, in order to 
estimate consumer exposure and to allow quantification of the impact on human exposure related 
to establishment of microbiological criteria.  
• Research needs to be conducted to establish the relationship between detection of NoV in oysters 
by PCR and human health consequences. 
• Further studies are needed to establish and optimise the effectiveness of depuration and relaying 
for NoV reduction using the standardised CEN method. 
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